Literature DB >> 18710254

Acid-degradable polyurethane particles for protein-based vaccines: biological evaluation and in vitro analysis of particle degradation products.

Eric M Bachelder1, Tristan T Beaudette, Kyle E Broaders, Sergey E Paramonov, Jesse Dashe, Jean M J Fréchet.   

Abstract

Acid-degradable particles containing a model protein antigen, ovalbumin, were prepared from a polyurethane with acetal moieties embedded throughout the polymer, and characterized by dynamic light scattering and transmission electron microscopy. The small molecule degradation byproduct of the particles was synthesized and tested in vitro for toxicity indicating an LC 50 of 12,500 microg/mL. A new liquid chromatography-mass spectrometry technique was developed to monitor the in vitro degradation of these particles. The degradation byproduct inside RAW macrophages was at its highest level after 24 h of culture and was efficiently exocytosed until it was no longer detectable after 4 days. When tested in vitro, these particles induced a substantial increase in the presentation of the immunodominant ovalbumin-derived peptide SIINFEKL in both macrophages and dendritic cells. In addition, vaccination with these particles generated a cytotoxic T-lymphocyte response that was superior to both free ovalbumin and particles made from an analogous but slower-degrading acid-labile polyurethane polymer. Overall, we present a fully degradable polymer system with nontoxic byproducts, which may find use in various biomedical applications including protein-based vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710254      PMCID: PMC2650432          DOI: 10.1021/mp800068x

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  39 in total

1.  Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.

Authors:  N H Carbonetti; R G Tuskan; G K Lewis
Journal:  AIDS Res Hum Retroviruses       Date:  2001-06-10       Impact factor: 2.205

2.  A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels.

Authors:  Niren Murthy; Mingcheng Xu; Stephany Schuck; Jun Kunisawa; Nilabh Shastri; Jean M J Fréchet
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

3.  Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  Pharm Dev Technol       Date:  2003       Impact factor: 3.133

4.  A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers.

Authors:  Niren Murthy; Yi X Thng; Stephany Schuck; Ming C Xu; Jean M J Fréchet
Journal:  J Am Chem Soc       Date:  2002-10-23       Impact factor: 15.419

5.  pH-triggered microparticles for peptide vaccination.

Authors:  W Nicholas Haining; Daniel G Anderson; Steven R Little; Michael S von Bergwelt-Baildon; Angelo A Cardoso; Pedro Alves; Kostas Kosmatopoulos; Lee M Nadler; Robert Langer; Daniel S Kohane; Michael S von Berwelt-Baildon
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

6.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

7.  Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.

Authors:  Manas Mandal; Kyung-Dall Lee
Journal:  Biochim Biophys Acta       Date:  2002-06-13

Review 8.  Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates.

Authors:  Paolo Caliceti; Francesco M Veronese
Journal:  Adv Drug Deliv Rev       Date:  2003-09-26       Impact factor: 15.470

Review 9.  New tools for antigen delivery to the MHC class I pathway.

Authors:  Gabriel Morón; Gilles Dadaglio; Claude Leclerc
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

10.  Fully acid-degradable biocompatible polyacetal microparticles for drug delivery.

Authors:  Sergey E Paramonov; Eric M Bachelder; Tristan T Beaudette; Stephany M Standley; Cameron C Lee; Jesse Dashe; Jean M J Fréchet
Journal:  Bioconjug Chem       Date:  2008-03-29       Impact factor: 4.774

View more
  9 in total

1.  Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.

Authors:  Suzanne Foster; Craig L Duvall; Emily F Crownover; Allan S Hoffman; Patrick S Stayton
Journal:  Bioconjug Chem       Date:  2010-11-02       Impact factor: 4.774

2.  Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.

Authors:  Fang Wu; Sherry A Wuensch; Mitra Azadniv; Mohammad R Ebrahimkhani; I Nicholas Crispe
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

3.  In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.

Authors:  Eric M Bachelder; Tristan T Beaudette; Kyle E Broaders; Jean M J Fréchet; Mark T Albrecht; Alfred J Mateczun; Kristy M Ainslie; John T Pesce; Andrea M Keane-Myers
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

4.  Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine.

Authors:  Meital Eckshtain-Levi; Cole J Batty; Liubov M Lifshits; Brandon McCammitt; Kathryn M Moore; Eva A Amouzougan; Rebeca T Stiepel; Eliza Duggan; Ted M Ross; Eric M Bachelder; Kristy M Ainslie
Journal:  ACS Appl Mater Interfaces       Date:  2022-06-15       Impact factor: 10.383

5.  In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines.

Authors:  Tristan T Beaudette; Eric M Bachelder; Joel A Cohen; Allie C Obermeyer; Kyle E Broaders; Jean M J Fréchet; Eun-Suk Kang; Ines Mende; William W Tseng; Matthew G Davidson; Edgar G Engleman
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

6.  Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.

Authors:  Elizabeth Graham-Gurysh; Kathryn M Moore; Andrew B Satterlee; Kevin T Sheets; Feng-Chang Lin; Eric M Bachelder; C Ryan Miller; Shawn D Hingtgen; Kristy M Ainslie
Journal:  Mol Pharm       Date:  2018-02-02       Impact factor: 4.939

7.  Smart Nanoformulation Based on Stimuli-Responsive Nanogels and Curcumin: Promising Therapy against Colon Cancer.

Authors:  Lizbeth A Manzanares-Guevara; Angel Licea-Claverie; Irasema Oroz-Parra; Johanna Bernaldez-Sarabia; Fernando Diaz-Castillo; Alexei F Licea-Navarro
Journal:  ACS Omega       Date:  2020-04-15

8.  Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines.

Authors:  Omar A Ali; Edward Doherty; David J Mooney; Dwaine Emerich
Journal:  Biomatter       Date:  2011 Jul-Sep

Review 9.  Multiparametric Material Functionality of Microtissue-Based In Vitro Models as Alternatives to Animal Testing.

Authors:  Elena Stengelin; Julian Thiele; Sebastian Seiffert
Journal:  Adv Sci (Weinh)       Date:  2022-01-18       Impact factor: 16.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.